You have reached the HIVandHepatitis.com legacy site. Please visit our new site at hivandhepatitis.com

 Google Custom Search

PRO 140 and PRO 2000


PRO 140 is a humanized monoclonal antibody designed to block the ability of HIV to infect cells by inhibiting virus-cell binding.

Monoclonal Antibody PRO 140 Suppresses HIV Viral Load with Once-weekly Dosing
5-7-2010

Large Trial Finds PRO 2000 Microbicide Is Ineffective in Preventing HIV Infection in Women
12-15-2009

Monoclonal Antibody PRO 140 Demonstrates Good Tolerability and Potent Activity against CCR5-tropic HIV
10-06-2009

Newer Anti-HIV Drugs and How to Use Them: Part 2
6-22-2009

Experimental HIV Entry Inhibitor PRO 140 Demonstrates Favorable Activity in Phase 2 Trial
11-08-2008


 

 


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


FDA-approved HIV
and AIDS Treatments
Protease Inhibitors PIs
non Nucleoside Reverse
  
Transcriptase Inhibitors nNRTIs
Nucleoside / Nucleotide
  
Reverse Transcriptase Inhibitors NRTIs
Fixed-dose Combinations
Entry / Fusion Inhibitors EIs
Integrase Inhibitors

Experimental Treatments

HIV and AIDS
Articles by Topic
Adverse Events
Opportunistic Infections
Metabolic Complications
Lipodystrophy - Fat Redistribution
Treatment Guidelines
Women/Children